kanamycin a has been researched along with Infection, Mycobacterium avium-intracellulare in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagawa, S; Hebisawa, A; Kawabe, Y; Kurashima, A; Machida, K; Masuda, K; Miyamoto, M; Nagai, H; Nagayama, N; Ohashi, R; Tamura, A; Tsuchiya, K; Yotsumoto, H | 1 |
| Kurashima, A; Mikami, J; Mita, M; Nishimura, T; Ohtawa, S; Saito, M; Suzuki, A | 1 |
| Tanaka, E | 1 |
| Amitani, R; Kimoto, T; Kuze, F; Matsumoto, H; Murayama, T; Niimi, A; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Watanabe, I | 1 |
| Tsukamura, M | 1 |
| Saito, H; Sato, K; Tomioka, H; Yoneyama, T | 1 |
| Saito, H; Sato, K | 1 |
2 trial(s) available for kanamycin a and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary | 1996 |
Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Ethambutol; Female; Fluoroquinolones; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Survival Analysis; Treatment Outcome | 1999 |
5 other study(ies) available for kanamycin a and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
[Case of pulmonary mycobacterium avium complex disease, showing hypersensitivity pneumonitis-like diffuse shadow].
Topics: Alveolitis, Extrinsic Allergic; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prednisolone; Steam Bath; Treatment Outcome; Tuberculosis, Pulmonary; Water Microbiology | 2006 |
[Clinical efficacy of kanamycin for Mycobacterium avium complex disease].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin | 2008 |
[Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Topics: Adult; Aged; Drug Therapy, Combination; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Carriers; Female; Kanamycin; Liposomes; Lung; Macrophages; Mice; Mice, Inbred BALB C; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phagocytosis; Tissue Distribution | 1991 |
Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
Topics: Animals; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Liver; Lung; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifamycins; Spleen | 1989 |